Discovery on Target 2026 has ended. This guide stays up as the record of who was there. Next: Discovery on Target 2027, Oct 18–21, 2027 in Boston

Biogen at Discovery on Target 2026

Sep 28 – Oct 1, 2026 Boston, MA ~1.1k attendees Website

Biogen brings 2 presentations to Discovery on Target 2026 in Boston. Its program centres on strategic engineering of TfR1-mediated transcytosis for antibodies against challenging targets. It also weighs a modality-agnostic approach to difficult drug targets.

OrganizationDiscovery on Target 2026 Attendance
Biogen
Cambridge, MA
Large pharma
Biotechnology company with marketed medicines for neurological and neurodegenerative diseases.
Panel
Tue Sep 29
5:00pm–6:00pm
Tackling Difficult Drug Targets: Having a Modality-Agnostic & Technology-Nimble Approach
Plenary · with Drug Hunter, Bristol Myers Squibb, Amgen +3 more
Novel drug modalitiesInnovative discovery technologies
Talk
Thu Oct 1
4:05pm–4:35pm
Strategic Engineering of TfR1-Mediated Transcytosis
Antibodies Against Challenging Targets

Explore the full Discovery on Target 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full Discovery on Target 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Biogen

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Discovery on Target or its organizers. Submit a correction